Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multinational Retrospective Study
Language English Country Canada Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
36642436
DOI
10.3899/jrheum.220851
PII: jrheum.220851
Knihovny.cz E-resources
- Keywords
- ANCA-associated vasculitis, cardiovascular events, myocardial infarction, risk factors, stroke,
- MeSH
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis * MeSH
- Kidney MeSH
- Humans MeSH
- Antibodies, Antineutrophil Cytoplasmic * MeSH
- Retrospective Studies MeSH
- Risk Factors MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Antibodies, Antineutrophil Cytoplasmic * MeSH
OBJECTIVE: To investigate the occurrence of cardiovascular events (CVEs) in a large cohort of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) across the European Union, China, Turkey, Russia, the United Kingdom, and the USA. METHODS: Patients with a definite diagnosis of AAV who were followed for ≥ 3 months and had sufficient documentation were included. Data on myocardial infarction (MI) and stroke were collected retrospectively from tertiary vasculitis centers. Univariate and multivariate Cox regression models were used to estimate hazard ratios (HRs) and 95% CIs. RESULTS: Over a median follow-up of 62.0 months (IQR 22.6-100.0), CVEs (mostly MIs) occurred in 245 (10.7%) of 2286 patients with AAV, with a higher frequency in China and the UK. On multivariate regression analysis, older age (55-64.9 yrs, HR 2.93, 95% CI 1.99-4.31), smoking (HR 1.98, 95% CI 1.48-2.64), Chinese origin (HR 4.24, 95% CI 3.07-5.85), and pulmonary (HR 1.50, 95% CI 1.09-2.06) and kidney (HR 3.02, 95% CI 2.08-4.37) involvement were independent variables associated with a higher occurrence of CVEs. CONCLUSION: We showed that geographic region and both traditional and disease-specific (kidney involvement in particular) factors were independently associated with CVEs. Proper assessment and management of modifiable cardiovascular (CV) risk factors are essential for prevention of CV morbidity in patients with AAV.
C Rahmattulla PhD Department of Pathology Leiden University Medical Center Leiden the Netherlands
E Makarov MD Faculty of Medicine Lomonosov Moscow State University Moscow Russia
L O'Neill MD University Hospital Galway Dublin Ireland
S Moran MD Trinity Health Kidney Centre Trinity Translational Medicine Institute Dublin Ireland
References provided by Crossref.org